Average Co-Inventor Count = 4.33
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (16 from 1,151 patents)
2. Van Drie, John H. (0 patent)
3. Pitlik, Janos (0 patent)
4. Pernie, Robert B. (0 patent)
16 patents:
1. 8691758 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
2. 8536136 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
3. 8486989 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
4. 8426359 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
5. 8217048 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
6. 8039623 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
7. 7906550 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
8. 7745444 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
9. 7683033 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
10. 7378422 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
11. 7365092 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
12. 7273885 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
13. 7241796 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
14. 7208600 - Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases
15. 7109172 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease